Paper26317650
An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
Liao MY and 7 others. Oncotarget, 2015. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer. Papers, record 26317650. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26317650
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Cell Adhesion Molecules | Major topic |
| Colonic Neoplasms | Major topic |
| Xenograft Model Antitumor Assays | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Apoptosis | |
| Blotting, Western | |
| Camptothecin | |
| Cell Line, Tumor | |
| Cell Survival | |
| Dose-Response Relationship, Drug | |
| Drug Synergism | |
| Epithelial Cell Adhesion Molecule | |
| Flow Cytometry | |
| Fluorouracil | |
| HCT116 Cells | |
| Humans | |
| Irinotecan | |
| Leucovorin | |
| Mice, Inbred NOD | |
| Mice, SCID | |
| Molecular Targeted Therapy | |
| Vitamin B Complex |
Source PubMed
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15175435 | Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15175435 | PubMed |
| 2 | 21799003 | Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21799003 | PubMed |
| 3 | 19858489 | p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19858489 | PubMed |
| 4 | 17538158 | Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag? | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17538158 | PubMed |
| 5 | 11080501 | Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM). | J Biol Chem | 2001 | https://conductscience.org/library/papers/11080501 | PubMed |
| 6 | 18687126 | Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. | Breast Cancer Res | 2008 | https://conductscience.org/library/papers/18687126 | PubMed |
| 7 | 17548814 | Phenotypic characterization of human colorectal cancer stem cells. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17548814 | PubMed |
| 8 | 22989882 | Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22989882 | PubMed |
| 9 | 11578913 | Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma. | Crit Rev Oncol Hematol | 2001 | https://conductscience.org/library/papers/11578913 | PubMed |
| 10 | 17622246 | Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17622246 | PubMed |
| 11 | 18006828 | Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. | Cancer Res | 2007 | https://conductscience.org/library/papers/18006828 | PubMed |
| 12 | 19260824 | Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity. | Biochem J | 2009 | https://conductscience.org/library/papers/19260824 | PubMed |
| 13 | 16775119 | Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. | J Clin Pathol | 2008 | https://conductscience.org/library/papers/16775119 | PubMed |
| 14 | 22024571 | Cysteine cathepsins: from structure, function and regulation to new frontiers. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22024571 | PubMed |
| 15 | 15569986 | ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15569986 | PubMed |
| 16 | 9882520 | The structural analysis of adhesions mediated by Ep-CAM. | Exp Cell Res | 1999 | https://conductscience.org/library/papers/9882520 | PubMed |
| 17 | 23316711 | Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy. | Expert Opin Drug Deliv | 2013 | https://conductscience.org/library/papers/23316711 | PubMed |
| 18 | 8797845 | Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. | Eur J Biochem | 1996 | https://conductscience.org/library/papers/8797845 | PubMed |
| 19 | 8954717 | Cell contact-dependent signaling. | Dev Biol | 1996 | https://conductscience.org/library/papers/8954717 | PubMed |
| 20 | 23228632 | CHC promotes tumor growth and angiogenesis through regulation of HIF-1α and VEGF signaling. | Cancer Lett | 2013 | https://conductscience.org/library/papers/23228632 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926737 | Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42926737 | PubMed |
| 41430314 | EpCAM activates the ERK-EGR1 signaling axis and promotes TNF-α-induced the progression of anaplastic thyroid cancer. | J Transl Med | 2025 | https://conductscience.org/library/papers/41430314 | PubMed |
| 39443938 | CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39443938 | PubMed |
| 39010070 | Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/39010070 | PubMed |
| 38612911 | Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612911 | PubMed |
| 37588226 | Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance. | Genes Dis | 2024 | https://conductscience.org/library/papers/37588226 | PubMed |
| 37566162 | Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. | Arch Immunol Ther Exp (Warsz) | 2023 | https://conductscience.org/library/papers/37566162 | PubMed |
| 37543570 | Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis. | J Transl Med | 2023 | https://conductscience.org/library/papers/37543570 | PubMed |
| 37192201 | Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1. | PLoS One | 2023 | https://conductscience.org/library/papers/37192201 | PubMed |
| 36918661 | Characterization of human anti-EpCAM antibodies for developing an antibody-drug conjugate. | Sci Rep | 2023 | https://conductscience.org/library/papers/36918661 | PubMed |
| 36129635 | A Novel Immunotoxin Targeting Epithelial Cell Adhesion Molecule Using Single Domain Antibody Fused to Diphtheria Toxin. | Mol Biotechnol | 2023 | https://conductscience.org/library/papers/36129635 | PubMed |
| 35625820 | Implication of Different Tumor Biomarkers in Drug Resistance and Invasiveness in Primary and Metastatic Colorectal Cancer Cell Lines. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625820 | PubMed |
| 34586565 | The expression and clinical significance of GPR39 in colon cancer. | Ir J Med Sci | 2022 | https://conductscience.org/library/papers/34586565 | PubMed |
| 33154781 | The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma. | Oncol Lett | 2020 | https://conductscience.org/library/papers/33154781 | PubMed |
| 33101285 | Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture. | Front Immunol | 2020 | https://conductscience.org/library/papers/33101285 | PubMed |
| 32764280 | Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells. | Cells | 2020 | https://conductscience.org/library/papers/32764280 | PubMed |
| 32648337 | Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32648337 | PubMed |
| 32507912 | Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years? | Cancer Metastasis Rev | 2020 | https://conductscience.org/library/papers/32507912 | PubMed |
| 31656694 | Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications. | Biochem Pharmacol (Los Angel) | 2016 | https://conductscience.org/library/papers/31656694 | PubMed |
| 31367787 | Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines. | Cancer Chemother Pharmacol | 2019 | https://conductscience.org/library/papers/31367787 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26317650
GET https://conductscience.org/api/papers/v1/26317650/references?page=2